![]() Vice-President Director General Noboru Yumoto |
![]() Deputy Director General Masanao Oda |
Director, Research Planning Office Tomohiro Tamura TEL:029-862-6032 E-mail: |
Development of technologies to create advanced and comprehensive drugs and medical technologies to protect healthIn order to solve issues such as disease prevention, early treatment, and personalized medicine, we are developing regenerative-medicine technologies and advanced healthcare support technologies using cell-manipulation and biomaterial technologies, and an infrastructure for the development of medical equipment. For disease prevention and early diagnosis, we are developing technologies to characterize and analyze the functions of biomolecules. We are also developing high-efficiency drug discovery techniques to cut development costs without compromising safety through the amalgamation of information processing and bioanalysis. |
![]() |
| Evaluation of liver fibrosis stage of chronic hepatitis patients using glycobiomarker |
Development of technologies to achieve healthy lifeIn order to ensure a healthy life both mentally and physically, it is important to solve the issues of elderly care and maintenance and improvement of health, as well as mental issues associated with social anxiety. We are developing technologies to quantitatively evaluate mental and physical conditions, including stress, and to restore, maintain, and improve health through personalized medication and rehabilitation, with a view to developing technologies to facilitate healthy living. |
|
![]() |
|
| Development of an objective examination for olfactory malfunction using magnetic fields of the brain for objective olfactory diagnosis | |
Development of technologies to efficiently manufacture high-quality substances using bioprocesses that help to reduce industrial environmental loadsWith a view to extending the range of application of bioprocesses (material production using microbes and enzymes) that provide much higher reaction selectivity than chemical processes and allow efficient production of high-value-added compounds, we are searching for microbial resources and useful genes and characterizing their functions. We are also developing high-efficiency biomanufacturing technologies, including technologies to improve the functions of biopolymers and improve and design bioprocesses, technologies to produce transgenic modified plants, and technologies to bring a closed system for transgenic plant production into practical use. |
![]() |
| Activation of vitamin D by actinomycete and pharmacological effect of hydroxylated vitamin D |
![]() |
| Closed-type transgenic plant production system for production of plant-made pharmaceuticals |